IL100183A - Preparations for the treatment of sleep disorders that contain a history of triazole - Google Patents

Preparations for the treatment of sleep disorders that contain a history of triazole

Info

Publication number
IL100183A
IL100183A IL10018391A IL10018391A IL100183A IL 100183 A IL100183 A IL 100183A IL 10018391 A IL10018391 A IL 10018391A IL 10018391 A IL10018391 A IL 10018391A IL 100183 A IL100183 A IL 100183A
Authority
IL
Israel
Prior art keywords
sleep
rem
composition
disorders
nefazodone
Prior art date
Application number
IL10018391A
Other languages
English (en)
Hebrew (he)
Other versions
IL100183A0 (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL100183A0 publication Critical patent/IL100183A0/xx
Publication of IL100183A publication Critical patent/IL100183A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10018391A 1990-12-03 1991-11-28 Preparations for the treatment of sleep disorders that contain a history of triazole IL100183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/620,696 US5116852A (en) 1990-12-03 1990-12-03 Treatment of sleep disorders

Publications (2)

Publication Number Publication Date
IL100183A0 IL100183A0 (en) 1992-08-18
IL100183A true IL100183A (en) 1996-12-05

Family

ID=24487000

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10018391A IL100183A (en) 1990-12-03 1991-11-28 Preparations for the treatment of sleep disorders that contain a history of triazole

Country Status (11)

Country Link
US (1) US5116852A (de)
EP (1) EP0493687B1 (de)
JP (1) JP3062974B2 (de)
AT (1) ATE136777T1 (de)
CA (1) CA2056201A1 (de)
DE (1) DE69118859T2 (de)
DK (1) DK0493687T3 (de)
ES (1) ES2087217T3 (de)
GR (1) GR3019692T3 (de)
IL (1) IL100183A (de)
MX (1) MX9101994A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
US5502047A (en) * 1993-03-22 1996-03-26 Kavey; Neil B. Treatment for insomnia
EP0769297A1 (de) 1995-10-17 1997-04-23 Bristol-Myers Squibb Company Verwendung von Nefazodon für die Herstellung eines Medikaments zur Behandlung von Panikanfällen
AU2452397A (en) * 1996-07-31 1998-02-20 Bristol-Myers Squibb Company Nefazodone: use in migraine prophylaxis
US5852020A (en) * 1996-11-22 1998-12-22 Bristol-Myers Squibb Company Nefazodone: use in treating post traumatic stress disorder
WO1998024411A2 (en) * 1996-12-04 1998-06-11 Bristol-Myers Squibb Company Method for oral administration of buspirone
DE69930952T2 (de) * 1998-11-02 2006-08-31 Alza Corp., Mountain View Verfahren und Vorrichtung zur kontrollierten Abgabe pharmazeutischer Mittel sowie Dosierungsform hierfür
EP1189616A2 (de) 1999-04-09 2002-03-27 Sepracor Inc. S-hydroxynefazodon
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
DE60028955T2 (de) 1999-04-09 2007-07-05 Sepracor Inc., Marlborough R-hydroxynefazodon
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
AU2003210598A1 (en) * 2002-01-18 2003-09-04 Hypnion Inc Treatment of sleep disorders using sleep target modulators
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
PT1691811E (pt) * 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
EP1737473A4 (de) * 2004-04-19 2009-08-26 Noven Therapeutics Llc Lithium-kombinationen und relevante verwendungen
US20100179215A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US8513299B2 (en) 2006-05-19 2013-08-20 Pernix Sleep, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20100227916A1 (en) * 2006-05-19 2010-09-09 Somaxon Pharmaceuticals, Inc N-desmethyl-doxepin and methods of using the same to treat sleep disorders
US20080058408A1 (en) 2006-05-19 2008-03-06 Rogowski Roberta L Low-dose doxepin for treatment of sleep disorders in elderly patients
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
CA2693992C (en) * 2006-07-20 2017-01-31 Somaxon Pharmaceuticals, Inc. Methods of improving the pharmacokinetics of doxepin
WO2008085567A1 (en) * 2006-10-04 2008-07-17 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20100105614A1 (en) 2006-10-25 2010-04-29 Somaxon Pharmaceuticals, Inc. Ultra low dose doxepin and methods of using the same to treat sleep disorders
WO2008070795A2 (en) 2006-12-06 2008-06-12 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
CA2721133C (en) 2007-04-13 2018-11-06 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations and methods of making and using the same
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
MX9101994A (es) 1992-06-01
EP0493687B1 (de) 1996-04-17
DE69118859T2 (de) 1996-09-05
US5116852A (en) 1992-05-26
JP3062974B2 (ja) 2000-07-12
GR3019692T3 (en) 1996-07-31
DK0493687T3 (da) 1996-05-13
EP0493687A2 (de) 1992-07-08
DE69118859D1 (de) 1996-05-23
ES2087217T3 (es) 1996-07-16
JPH04300873A (ja) 1992-10-23
EP0493687A3 (en) 1992-07-22
CA2056201A1 (en) 1992-06-04
ATE136777T1 (de) 1996-05-15
IL100183A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
US5116852A (en) Treatment of sleep disorders
US5840331A (en) Use of γ-hydroxybutyrate for the stimulation of sleep-related secretion growth hormone and prolactin
EP0236684B1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
HUT71889A (en) Pharmaceutical compositions containing terfenadine metabolites and their optically pure isomers for treating allergic disorders
DE69329400D1 (de) L-Dopa Ester enthaltende Zusammensetzung
US20100227916A1 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
IE61612B1 (en) Antiparkinson ergoline derivatives
HU202754B (en) Process for producing flavoxate derivatives and pharmaceutical compositions containing them as active components
CA2238770A1 (en) Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis
EP0217258B1 (de) Verwendung von Cholin oder Cholin freisetzenden Verbindungen zur Verringerung der Empfingdung von Ermüdung
US4686225A (en) Vinpocetine for pulmonary hemorrhage and edema
EP0694299A1 (de) Verwendung vom einem Bicycloheptan-Derivat
US4829068A (en) Treatment of disorders of the gastro-intestinal tract
HUP0203790A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrugokat tartalmazó gyógyszerkészítmények alkalmazása gyulladás kezelésére
EP1011679B1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3-benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
KR960700711A (ko) 뇌혈관성 질환의 치료 또는 예방용 약제(Medicament for treating or preventing cerebrovascular diseases)
US4375473A (en) Method
IT8247658A1 (it) Medicamenti a base di derivati condensati dell'imidazolo per il trattamento di disturbi urinari
US4156003A (en) Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine
CA1209047A (en) Therapeutic composition containing piracetam analog
US5362731A (en) Use of piribedil derivatives and analogs for the treatment of hyperactive or unstable bladders
US4271175A (en) Method of using 2-[N-(2,6-dichloro-phenyl)-N-allyl-amino]-2-imidazoline and salts thereof as bradycardiacs
NZ225426A (en) Anti-arrhythmic pharmaceutical compositions, in unit dosage form, containing 4-amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinoline
KR920003580B1 (ko) 동맥경화증 예방 및 치료제
RU2136309C1 (ru) Способ лечения хореи гентингтона

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees